17th Nov 2005 18:02
Skyepharma PLC17 November 2005 For immediate release 17 November 2005 SkyePharma PLC Rule 2.10 Announcement - Relevant Securities in Issue In accordance with Rule 2.10 of the City Code on Takeovers and Mergers,SkyePharma PLC confirms that, as at close of business on 16 November 2005,SkyePharma (Jersey) Limited, a wholly owned subsidiary of SkyePharma PLC, had inissue convertible bonds due 2024 totalling £69,594,000 in aggregate. TheInternational Securities Identification Number for the convertible bonds due2024 is XS0192041621. In addition SkyePharma PLC confirms that, as at close of business on 16 November2005, SkyePharma (Jersey) Limited, a wholly owned subsidiary of SkyePharma PLC,had in issue convertible bonds due 2025 totalling £20,000,000 in aggregate. TheInternational Securities Identification Number for the convertible bonds due2025 is XS0221445538. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L